We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-0.31%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$111B
AUM Growth
+$1.46B
Cap. Flow
+$2.6B
Cap. Flow %
2.33%
Top 10 Hldgs %
23.97%
Holding
4,345
New
253
Increased
2,150
Reduced
1,535
Closed
239

Sector Composition

Rank Sector Weight
1 Technology 14.74%
2 Financials 9%
3 Healthcare 8.22%
4 Consumer Discretionary 6.53%
5 Industrials 6.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KODK icon
3751
Kodak
KODK
$987M
$136K ﹤0.01%
19,914
-17,298
-46% -$126K
MAMA icon
3752
Mama's Creations
MAMA
$828M
$134K ﹤0.01%
+55,465
New +$145K
TXMD icon
3753
TherapeuticsMD
TXMD
$24M
$134K ﹤0.01%
3,610
-6,536
-64% -$290K
GRF
3754
Eagle Capital Growth Fund
GRF
$40.9M
$133K ﹤0.01%
14,140
+1,734
+14% +$16K
HL icon
3755
Hecla Mining
HL
$11.9B
$133K ﹤0.01%
24,119
+300
+1% +$1.87K
EGIO
3756
DELISTED
Edgio, Inc. Common Stock
EGIO
$133K ﹤0.01%
1,398
-704
-33% -$74.2K
ATCX
3757
DELISTED
Atlas Technical Consultants, Inc. Class A Common Stock
ATCX
$133K ﹤0.01%
13,085
+798
+6% +$8.25K
LUNA
3758
DELISTED
Luna Innovations Incorporated
LUNA
$133K ﹤0.01%
+13,967
New +$151K
BKD icon
3759
Brookdale Senior Living
BKD
$3B
$132K ﹤0.01%
20,944
-5,818
-22% -$41.5K
DXC icon
3760
CALL
DXC Technology
DXC
$1.73B
$132K ﹤0.01%
46,300
-1,700
-4% -$64.4K
SJT
3761
San Juan Basin Royalty Trust
SJT
$126M
$132K ﹤0.01%
26,100
+15,900
+156% +$77K
CARS icon
3762
Cars.com
CARS
$635M
$131K ﹤0.01%
10,391
-100
-1% -$1.26K
CLNE icon
3763
Clean Energy Fuels
CLNE
$377M
$131K ﹤0.01%
16,017
-7,010
-30% -$55.8K
NIM icon
3764
Nuveen Select Maturities Municipal Fund
NIM
$115M
$131K ﹤0.01%
12,034
SGMO
3765
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$131K ﹤0.01%
14,585
-90,650
-86% -$896K
NMI icon
3766
Nuveen Municipal Income
NMI
$130M
$130K ﹤0.01%
10,858
+553
+5% +$6.57K
IVR icon
3767
Invesco Mortgage Capital
IVR
$802M
$129K ﹤0.01%
4,102
+27
+0.7% +$877
MRC
3768
DELISTED
MRC Global
MRC
$129K ﹤0.01%
17,627
-17,349
-50% -$144K
SLV icon
3769
CALL
iShares Silver Trust
SLV
$31.5B
$129K ﹤0.01%
216,300
+82,000
+61% +$1.84M
PRVB
3770
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$128K ﹤0.01%
19,975
+2,550
+15% +$16.4K
PYPD icon
3771
PolyPid
PYPD
$90.7M
$127K ﹤0.01%
545
+13
+2% +$3.17K
HUYA
3772
Huya Inc
HUYA
$556M
$126K ﹤0.01%
+15,095
New +$174K
IAF
3773
abrdn Australia Equity Fund
IAF
$128M
$126K ﹤0.01%
7,121
+749
+12% +$14.2K
EXC icon
3774
CALL
Exelon
EXC
$46.2B
$125K ﹤0.01%
49,350
+8,692
+21% +$297K
MMAT
3775
DELISTED
Meta Materials Inc. Common Stock
MMAT
$125K ﹤0.01%
+216
New +$94.2K

Similar funds

Raymond James & Associates's Q3 2021 Portfolio in Review

As of Q3 2021, Raymond James & Associates held 4,345 positions worth $111B, up 1.3% from $110B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates's Q3 2021 filing shows 253 new, 2,150 increased, 1,535 reduced and 239 closed positions. Its largest new stake was GXO Logistics: 224,392 shares worth $17.6M. The largest sale was iShares Core S&P Mid-Cap ETF, an estimated $358M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q3 2021 buy was GXO Logistics: 224,392 shares worth $17.6M.
  • Raymond James & Associates added most to Vanguard Morningstar Mid-Cap ETF in Q3 2021, an estimated $569M increase.
  • Raymond James & Associates's biggest Q3 2021 reduction was iShares Core S&P Mid-Cap ETF, cutting an estimated $358M.
  • Raymond James & Associates fully exited Invesco S&P 500 Equal Weight Energy ETF in Q3 2021, selling an estimated $9.16M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $111B portfolio in Q3 2021.
  • Raymond James & Associates opened 253 new positions and closed 239 in Q3 2021.
  • Raymond James & Associates's portfolio value rose 1.3% quarter-over-quarter to $111B.

Based on Raymond James & Associates's 13F filing for Q3 2021, filed 2 Nov 2021.